BE study in China (for China) [Regulatives / Guidelines]

posted by Shuanghe  – Spain, 2020-06-05 10:56 (228 d 05:42 ago) – Posting: # 21499
Views: 577

Hi John,

» Does anyone know if there is a min sample size requirement for a pivotal (submission) BE study for regulatory submission in China? In US I believe it's n=12 (unless changed), not sure about China.

In the old guidance 18 to 24 subjects were mentioned so I guess that many people considered 18 as minimum number.

There is no minimum size requirement by the new guidance. It only mentions that statistical power should be ensured by the sample size. See link of guidances in that post.

All the best,
Shuanghe

Complete thread:

Activity
 Admin contact
21,305 posts in 4,442 threads, 1,487 registered users;
online 23 (0 registered, 23 guests [including 2 identified bots]).
Forum time: Tuesday 15:38 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5